Cellworks Singula - Personalized Therapy Biosimulation Reports

Cellworks Singula reports provide personalized response predictions to Standard Care therapies for front-line patients. The Singula report provides a Therapy Response Index (TRI) Score for every Standard Care drug for a given indication, ranking the impact of each therapy on the phenotype of a patient. This enables physicians to know the benefit from treatment prior to treatment, preventing unwanted rounds of therapy that would be ineffective.